share_log

On Jan 17, Jounce Therapeutics Received Notice From Nasdaq Co. Regained Compliance With Minimum Bid Price Requirement For Continued Listing On Nasdaq

On Jan 17, Jounce Therapeutics Received Notice From Nasdaq Co. Regained Compliance With Minimum Bid Price Requirement For Continued Listing On Nasdaq

1 月 17 日,Jounce 治療學收到納斯達克公司的通知。重新符合持續在納斯達克上市的最低買入價要求
Benzinga Real-time News ·  2023/01/20 08:13

on Jan 17, Jounce Therapeutics Received Notice From Nasdaq Co. Regained Compliance With Minimum Bid Price Requirement For Continued Listing On Nasdaq

1 月 17 日,Jounce 治療學收到納斯達克公司的通知。重新符合持續在納斯達克上市的最低買入價要求

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論